AFP and neoplasm: Existing prediction models predominantly rely on preoperative factors, such as alpha-fetoprotein (AFP) levels and the tumor burden score (TBS)—a continuous variable calculated from tumor size and number—to estimate recurrence-free survival (RFS) post-hepatectomy.5,6